Target intelligence / Profile preview

Porphyromonas gingivalis and other pathogenic oral biofilm bacteria

Molecular classification
Gram-negative bacteria, Anaerobic bacteria, Pathogen
01

Overview

Porphyromonas gingivalis is a Gram-negative, anaerobic bacterium recognized as a keystone pathogen in the development of chronic periodontitis (Hajishengallis et al., 2012, Nature Reviews Microbiology). It typically resides within a complex polymicrobial biofilm alongside other Red Complex pathogens like Tannerella forsythia and Treponema denticola (Socransky et al., 1998, Journal of Clinical Periodontology). These bacteria utilize specialized virulence factors, particularly gingipain proteases, to degrade host tissues and subvert the immune system (Potempa et al., 2003, Periodontology 2000). Beyond the oral cavity, P. gingivalis has been implicated in the pathogenesis of systemic conditions such as Alzheimer's disease, where its proteases have been detected in brain tissue (Dominy et al., 2019, Science Advances). Therapeutic approaches include the use of broad-spectrum antibiotics, local antiseptics, and emerging small-molecule inhibitors like atuzaginstat designed to block specific bacterial enzymes (Cortexyme, 2021, Clinical Trial Data). Targeting these organisms is essential for managing both local periodontal destruction and the associated systemic inflammatory burden. However, the complexity of the oral microbiome presents challenges in achieving selective eradication without causing dysbiosis.

Other names
Red complex bacteriaPeriodontal pathogensOral microbiome pathogensP. gingivalisTannerella forsythiaTreponema denticola
02

Mechanism of action

Inhibition of bacterial DNA synthesis, inhibition of cell wall synthesis, inhibition of gingipain proteases, and disruption of biofilm matrix.

03

Biological functions

Biofilm formationProteolysisImmune evasionInflammation inductionTissue degradation
04

Disease associations

InfectionInflammationNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Antibiotic resistanceDisruption of commensal oral flora (dysbiosis)Systemic toxicity of protease inhibitorsPoor penetration into deep periodontal pockets
06

Interacting drugs

Metronidazole

4 more in the full profile.

07

Biomarkers

Porphyromonas gingivalis DNAGingipain levelsPro-inflammatory cytokines (IL-1beta, TNF-alpha)Bleeding on probing (BOP)

Beyond the preview

Go deeper on Porphyromonas gingivalis and other pathogenic oral biofilm bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porphyromonas gingivalis and other pathogenic oral biofilm bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call